The vaccine company will utilize the Datatrak one unified software suite to conduct a series of trials.
Datatrak CEO Laurence P Birch said the input of the specialty biologics company into the growth of their products would be invaluable.
"Signing another Enterprise client demonstrates the commitment to Datatrak’s unified product suite and exemplifies the industry’s need for a single solution to conducting clinical trials from Concept to Cure," Birch added.